HER-2-directed, small-molecule antagonists - Wikidata - awgldk - TriplyDB

HER-2-directed, small-molecule antagonists

HER-2-directed, small-molecule antagonists

http://www.wikidata.org/entity/Q37336019

about

Computational analyses of curcuminoid analogs against kinase domain of HER2

P2860

Q34084939-C4CE12FD-5E2C-40A7-B2A1-D4F0324B86DC

P2860

HER-2-directed, small-molecule antagonists

http://www.wikidata.org/entity/Q37336019

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on December 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

HER-2-directed, small-molecule antagonists

@en

HER-2-directed, small-molecule antagonists.

@nl

type

label

HER-2-directed, small-molecule antagonists

@en

HER-2-directed, small-molecule antagonists.

@nl

prefLabel

HER-2-directed, small-molecule antagonists

@en

HER-2-directed, small-molecule antagonists.

@nl

P1433

Q37336019-E29B2A6E-D5A2-48A0-8EE1-BC6B1C347746

P1476

Q37336019-81E79039-7DB6-4AE6-ACED-432735334908

P2093

Q37336019-27E4C2DF-76BF-4C0A-8D8B-BB0621A17ACA

Q37336019-5F6C4908-4A3F-4375-B422-534A66B3A657

P2860

Q37336019-03F1A06E-EF6C-4900-A705-11F8CA21D1B4

Q37336019-05ABB423-2B8E-4CEA-A9E8-1ED97EB58719

Q37336019-08BD6582-4A0A-4DA6-AB93-C9A96C6CDDAE

Q37336019-08C62E03-F0A4-49BA-AD4C-F4D79916A7DB

Q37336019-08E25786-74F6-402C-A95C-92F1D80D0A84

Q37336019-10084199-1779-4BE1-99D6-CE391CF438C0

Q37336019-105A3E30-40E5-4E36-AFF6-F56B9108CFC6

Q37336019-119E7F0A-27B0-4499-97E2-F40A58D91704

Q37336019-1A7E6E59-ADA6-425E-87A1-6BBF2DC79DC0

Q37336019-1E8B051D-7D17-4C09-81A3-BA57F2340260

P304

Q37336019-BDFCC1C5-7ED8-4392-BE9A-7FD5C73FB065

P31

Q37336019-8D315CE2-4358-4851-A154-B70F68C59865

P433

Q37336019-DB1B34AD-47F2-4F62-96C8-1F5D8CB2989B

P478

Q37336019-E30B912B-2207-418B-A4E3-0CD746EF0773

P577

Q37336019-DBD470EB-6A61-4215-AF05-EEDD3F754EDA

P698

Q37336019-283F91BF-5982-49A1-924E-540F291A0AFF

P932

Q37336019-0A87085D-323D-498E-B7BD-3DD88BBE103F

P1433

Current Opinion in Investigational Drugs

P1476

HER-2-directed, small-molecule antagonists

@en

P2093

Mark M Moasser

http://www.w3.org/2001/XMLSchema#string

Michelle Arkin

http://www.w3.org/2001/XMLSchema#string

P2860

An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor

Escape from HER-family tyrosine kinase inhibitor therapy by the kinase-inactive HER3

A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/neuregulin and epidermal growth factor

The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP

The ErbB2/ErbB3 heterodimer functions as an oncogenic unit: ErbB2 requires ErbB3 to drive breast tumor cell proliferation

Structural mechanism for STI-571 inhibition of abelson tyrosine kinase

Crystal structures of the kinase domain of c-Abl in complex with the small molecule inhibitors PD173955 and imatinib (STI-571)

Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor

Structures of Lung Cancer-Derived EGFR Mutants and Inhibitor Complexes: Mechanism of Activation and Insights into Differential Inhibitor Sensitivity

The characterization of novel, dual ErbB-2/EGFR, tyrosine kinase inhibitors: potential therapy for cancer

P304

1264-1276

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2008-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19037833

http://www.w3.org/2001/XMLSchema#string

P932

3031872

http://www.w3.org/2001/XMLSchema#string